Show source-provided references
2. Mochane, M.J., Motsoeneng, T.S., Sadiku, E.R., Mokhena, T.C., and Sefadi, J.S. (2019). Morphology and properties of electrospun PCL and its composites for medical applications: A mini review. Appl. Sci., 9.
10.3390/app9112205 ↗3. Physical and antibacterial properties of peppermint essential oil loaded poly(ε-caprolactone) (pcl) electrospun fiber mates for wound healing
10.3389/fbioe.2019.00346 ↗4. Yung, S.M., Min, S.K., Lee, H.C., Kwon, Y.S., Jung, M.H., and Shin, H.S. (2016). Spirulina-pcl nanofiber wound dressing to improve cutaneous wound healing by enhancing antioxidative mechanism. J. Nanomater., 6135727.
10.1155/2016/6135727 ↗7. Souza, M.A., Sakamoto, K.Y., and Mattoso, L.H.C. (2014). Release of the diclofenac sodium by nanofibers of poly(hydroxybutyrate-co-3-hydroxyvalerate) obtained from electrospinning and solution blow spinning. J. Nanomater., 129035.
10.1155/2014/129035 ↗8. Drug delivery from polymer-based nanopharmaceuticals—An experimental study complemented by simulations of selected diffusion processes
10.3389/fbioe.2019.00037 ↗11. Nanonet-nano fiber electrospun mesh of PCL–chitosan for controlled and extended release of diclofenac sodium
10.1039/D0NR05968D ↗13. Calzoni, E., Cesaretti, A., Polchi, A., di Michele, A., Tancini, B., and Emiliani, C. (2019). Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies. J. Funct. Biomater., 10.
10.3390/jfb10010004 ↗14. Characterization, drug loading and antibacterial activity of nanohydroxyapatite/polycaprolactone (nHA/PCL) electrospun membrane
10.1007/s13205-017-0889-0 ↗17. Rios-Doria, J., Carie, A., Costich, T., Burke, B., Skaff, H., Panicucci, R., and Sill, K. (2012). A versatile polymer micelle drug delivery system for encapsulation and in vivo stabilization of hydrophobic anticancer drugs. J. Drug. Deliv., 951741.
10.1155/2012/951741 ↗18. Mucoadhesive electrospun nanofibers for drug delivery systems: Applications of polymers and the parameter’ roles
10.2147/IJN.S193328 ↗19. Fast-dissolving antibacterial nanofibers of cyclodextrin/antibiotic inclusion complexes for oral drug delivery
10.1016/j.jcis.2020.11.072 ↗20. Nanofibers for drug delivery—incorporation and release of model molecules, influence of molecular weight and polymer structure
10.3762/bjnano.6.198 ↗21. Alven, S., Nqoro, X., Buyana, B., and Aderibigbe, B.A. (2020). Polymer-drug conjugate, a potential therapeutic to combat breast and lung cancer. Pharmaceutics, 12.
10.3390/pharmaceutics12050406 ↗23. Kostková, H., Schindler, L., Kotrchová, L., Kovář, M., Šírová, M., Kostka, L., and Etrych, T. (2017). Star polymer-drug conjugates with pH-controlled drug release and carrier degradation. J. Nanomater., 8675435.
10.1155/2017/8675435 ↗24. Effects of some electrospinning parameters on morphology of natural silk-based nanofibers
10.1002/app.29808 ↗25. Zafar, M., Najeeb, S., Khurshid, Z., Vazirzadeh, M., Zohaib, S., Najeeb, B., and Sefat, F. (2016). Potential of electrospun nanofibers for biomedical and dental applications. Materials, 9.
10.3390/ma9020073 ↗26. Electrospun poly-l-lactide scaffold for the controlled and targeted delivery of a synthetically obtained diclofenac prodrug to treat actinic keratosis
10.1016/j.actbio.2016.11.002 ↗27. Fabrication of electrospun poly(D,L lactide-co-glicolide) 80/20 scaffolds loaded with diclofenac sodium for tissue engineering
10.1186/s40001-015-0145-1 ↗30. Bioactive polymeric scaffolds for tissue engineering
35. Mayorek, N., Naftali-Shani, N., and Grunewald, M. (2010). Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activity. PLoS ONE, 5.
10.1371/journal.pone.0012715 ↗36. Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells
10.1016/j.lungcan.2009.06.012 ↗37. Valle, B.L., D’Souza, T., Becker, K.G., Wood, W.H., Zhang, Y., Wersto, R.P., and Morin, P.J. (2013). Non-Steroidal Anti-inflammatory Drugs Decrease E2F1 Expression and Inhibit Cell Growth in Ovarian Cancer Cells. PLoS ONE, 8.
10.1371/journal.pone.0061836 ↗39. Nugrahani, I., Utami, D., Permana, B., and Ibrahim, S. (2018). Development of the NSAID-L-Proline Amino Acid Zwitterionic Cocrystals. J. Appl. Pharm. Sci., 57–63.
10.7324/JAPS.2018.8408 ↗40. Bandeira, M., Borges, V., Gomes, J.P., Duarte, A., and Jordao, L. (2017). Insight on Klebsiella pneumoniae biofilms assembled on different surfaces using phenotypic and genotypic approaches. Microorganisms, 5.
10.3390/microorganisms5020016 ↗41. International Organization for Standardization (2011). Measurement of Antibacterial Activity on Plastics and Other Non-Porous Surfaces, International Organization for Standardization. ISO 22196.
42. Ezhilarasu, H., Ramalingam, R., Dhand, C., Lakshminarayanan, R., Sadiq, A., Gandhimathi, C., Ramakrishna, S., Bay, B.H., Venugopal, J.R., and Srinivasan, D.K. (2019). Biocompatible aloe vera and tetracycline hydrochloride loaded hybrid nanofibrous scaffolds for skin tissue engineering. Int. J. Mol. Sci., 20.
10.3390/ijms20205174 ↗44. Effect of changing solvents on poly(ε-caprolactone) nanofibrous webs morphology
45. Electrospinning of polycaprolactone nanofibers with DMF additive: The effect of solution properties on jet perturbation and fiber morphologies
10.1007/s12221-016-6045-3 ↗47. Electrospun polycaprolactone scaffolds using an ionic liquid as alternative solvent: Morphometric, mechanical and biological properties
48. Acetone, a sustainable solvent for electrospinning poly(ε-caprolactone) fibers: Effect of varying parameters and solution concentration on fibre diameter
10.1007/s10924-012-0436-3 ↗50. Cheremisinoff, N. (2008). Industrial Solvents Handbook, Marcel Dekker Inc.. [2nd ed.].
51. Liverani, L., and Boccaccini, A.R. (2016). Versatile production of poly(epsilon-caprolactone) fibers by electrospinning using benign solvents. Nanomaterials, 6.
10.3390/nano6040075 ↗53. Tammaro, L., Russo, G., and Vittoria, V. (2009). Encapsulation of diclofenac molecules into poly(ε-caprolactone) electrospun fibers for delivery protection. J. Nanomater., 238206.
10.1155/2009/238206 ↗54. Tuning surface texture of electrospun polycaprolactone fibers: Effects of solvent systems and relative humidity
55. Electrospinning of polycaprolactone in dichloromethane/dimethylformamide solvent system
56. Abutaleb, A., Lolla, D., Aljuhani, A., Shin, H.U., Rajala, J.W., and Chase, G.G. (2017). Effect of surfactants on the morphology and properties of electrospun polyetherimide fibers. Fibers, 5.
10.3390/fib5030033 ↗58. Šišková, A.O., Kozma, E., Opálek, A., Kroneková, Z., Kleinová, A., Nagy, Š., Kronek, J., Rydz, J., and Eckstein Andicsová, A. (2020). Diclofenac embedded in silk fibroin fibers as a drug delivery system. Materials, 13.
10.3390/ma13163580 ↗59. New applications of electron diffraction in the pharmaceutical industry: Polymorph determination by using a combination of electron diffraction and synchrotron X-ray powder diffraction techniques
10.1017/S1431927601020050 ↗60. Fini, A., Cavallari, C., and Ospitali, F. (2010). Diclofenac salts. V. Examples of polymorphism among diclofenac salts with alkyl-hydroxy amines studied by DSC and HSM. Pharmaceutics, 2.
10.3390/pharmaceutics2020136 ↗64. Thermal and Thermomechanical Behaviour of polycaprolactone and starch/polycaprolactone blends for biomedical applications
10.1002/mame.200500003 ↗65. Thermal Behaviour of diclofenac sodium: Decomposition of melting characteristics
10.1248/cpb.49.1245 ↗69. Diclofenac release from polycaprolactone 3D matrices produced by electrospinning: Influence of fiber structure and composition of the surrounding medium
10.1080/00914037.2018.1525720 ↗71. Szewczyk, P.K., Ura, P.D., Metwally, S., Kanpczyk-Korczak, J., Gajek, M., Marzec, M.M., Bernasik, A., and Stachewicz, U. (2019). Roughness and fiber fraction dominated wetting of electrospun fiber-based porous meshes. Polymers, 11.
10.3390/polym11010034 ↗72. Fabrication of superhydrophobic polycaprolactone/beeswax electrospun membranes for high-efficiency oil/water separation
10.1039/C6RA26123J ↗73. Diclofenac-Choline Antioxidant Activity Investigated by Means of Luminol Amplified Chemiluminescence of Human Neutrophil Bursts and Electron Paramagnetic Resonance Spectroscopy
74. Leão, C., Borges, A., and Simões, M. (2020). NSAIDs as drug repurposing strategy for biofilm control. Antibiotics, 9.
10.3390/antibiotics9090591 ↗76. On the etiological relevance of Escherichia coli and staphylococcus aureus in superficial and deep infections—A hypothesis-forming, retrospective assessment
10.1556/1886.2019.00021 ↗77. Sarwar, M.N., Ullah, A., Haider, M.K., Hussain, N., Ullah, S., Hashimi, M., Khan, M.Q., and Kim, I.S. (2021). Evaluating antibacterial efficacy and biocompatibility of PAN nanofibers loaded with diclofenac sodium salt. Polymers, 13.
10.3390/polym13040510 ↗78. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management
10.1128/CMR.00134-14 ↗80. Characterization of the surface biocompatibility of the electrospun PCL-collagen nanofibers using fibroblasts
10.1021/bm050314k ↗82. PCL/PEG electrospun fibers as drug carriers for the controlled delivery of dipyridamole